Search

Your search keyword '"Halloran, Christopher"' showing total 497 results

Search Constraints

Start Over You searched for: Author "Halloran, Christopher" Remove constraint Author: "Halloran, Christopher"
497 results on '"Halloran, Christopher"'

Search Results

3. Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis

4. Genetic and functional analysis of chymotrypsin-like protease (CTRL) in chronic pancreatitis

5. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial

6. Determination of “borderline resectable” pancreatic cancer – A global assessment of 30 shades of grey

7. Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study

8. Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosis

10. Glycaemic control following total pancreatectomy: room for improvement?

11. Evidence Map of Pancreatic Surgery–A living systematic review with meta-analyses by the International Study Group of Pancreatic Surgery (ISGPS)

13. Early detection of pancreatic cancer

14. International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club

15. Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS)

17. Mechanism of mitochondrial permeability transition pore induction and damage in the pancreas: inhibition prevents acute pancreatitis by protecting production of ATP

19. Postpancreatectomy Acute Pancreatitis (PPAP): Definition and Grading from the International Study Group for Pancreatic Surgery (ISGPS)

20. Laparoscopic Staging in Patients with Newly Diagnosed Pancreatic Cancer

21. Arterial Resection in Pancreatic Cancer

24. Determination of “borderline resectable” pancreatic cancer – A global assessment of 30 shades of grey

27. Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma

31. Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial

32. Guidelines for the understanding and management of pain in chronic pancreatitis

33. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

35. Supplementary Table 3 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

36. Supplementary Table 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

37. Supplementary Table 4 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

38. Supplemental Methods from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

39. Data from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

40. Supplementary Table 2 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

41. Supplementary Figure 1 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

42. Supplementary Figure 2 from Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties

44. A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy

47. Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial

49. Contributors

Catalog

Books, media, physical & digital resources